Related Experiment Video
Updated: Nov 26, 2025
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.1K
Paradigm shift in efforts to end TB by 2025
K S Sachdeva1, Malik Parmar2, Raghuram Rao1
1Central TB Division, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
The Indian Journal of Tuberculosis
|December 14, 2020
Summary
This article reviews the evolution of India's Tuberculosis (TB) control programs, highlighting advancements in diagnostics, drugs, and public health initiatives. These efforts, including the National Tuberculosis Elimination Program (NTEP), aim to eradicate TB by 2025.
Area of Science:
- Public Health
- Infectious Disease Control
- Medical History
Background:
- Tuberculosis (TB) has been a persistent global health challenge throughout history.
- India has progressively evolved its TB control strategies, from the National Tuberculosis Control Program (NTCP) to the Revised National Tuberculosis Control Program (RNTCP) and now the National Tuberculosis Elimination Program (NTEP).
Observation:
- Significant progress has been made through increased funding, development of new drugs and diagnostics, improved healthcare access, and enhanced public health education.
- The proactive involvement of TB activism, media, private sector, political advocacy, and community engagement has been crucial.
- Ongoing vaccine trials offer renewed hope for a breakthrough in TB eradication efforts.
Findings:
- The current National Tuberculosis Elimination Program (NTEP) incorporates a paradigm shift in policy, emphasizing population-based vulnerability mapping and active case-finding.
- These strategies are expected to accelerate India's progress towards achieving TB elimination goals.
Implications:
- Continued investment in research, innovation, and the development of more effective drugs and vaccines is essential.
- These advancements will strengthen the global armamentarium against TB, bringing the goal of ending TB within reach.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.1K
06:07Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
Published on: June 6, 2025
715
Related Concept Videos
01:28Pulmonary Tuberculosis V
330
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
330
01:28Pulmonary Tuberculosis II
962
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
962
01:29Pulmonary Tuberculosis I
552
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
552
01:31Pulmonary Tuberculosis III
655
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
655
01:26Pulmonary Tuberculosis IV
296
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
296
01:26Methods Of Healthcare Delivery System
3.8K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.8K